155 related articles for article (PubMed ID: 33132120)
21. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
[TBL] [Abstract][Full Text] [Related]
22. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
23. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
[TBL] [Abstract][Full Text] [Related]
25. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H
Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190
[TBL] [Abstract][Full Text] [Related]
26. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
28. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
29. Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune-response in a humanized mice model.
Wang J; Shao L; Wu L; Ma W; Zheng Y; Hu C; Li F
Thorac Cancer; 2020 Jun; 11(6):1603-1612. PubMed ID: 32314522
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic
Ikemori R; Gabasa M; Duch P; Vizoso M; Bragado P; Arshakyan M; Luis IC; Marín A; Morán S; Castro M; Fuster G; Gea-Sorli S; Jauset T; Soucek L; Montuenga LM; Esteller M; Monsó E; Peinado VI; Gascon P; Fillat C; Hilberg F; Reguart N; Alcaraz J
Cancer Res; 2020 Jan; 80(2):276-290. PubMed ID: 31694906
[TBL] [Abstract][Full Text] [Related]
31. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
32. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
33. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.
Yu S; Li Y; Ren H; Zhou H; Ning Q; Chen X; Hu T; Yang L
Cancer Chemother Pharmacol; 2021 Feb; 87(2):207-215. PubMed ID: 33221963
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1.
Jin X; Pang W; Zhang Q; Huang H
J Int Med Res; 2019 Aug; 47(8):3745-3756. PubMed ID: 31117868
[TBL] [Abstract][Full Text] [Related]
35. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
36. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
37. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.
Wu Z; Fournel L; Stadler N; Liu J; Boullier A; Hoyeau N; Fléjou JF; Duchatelle V; Djebrani-Oussedik N; Agopiantz M; Ségal-Bendirdjian E; Gompel A; Alifano M; Melander O; Trédaniel J; Forgez P
Cancer Lett; 2019 Mar; 444():147-161. PubMed ID: 30583074
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of molecule GRP94 favors tumor progression in lung adenocarcinoma by interaction with regulatory T cells.
Duan XF; Xin YW
Thorac Cancer; 2020 Mar; 11(3):704-712. PubMed ID: 31970893
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
40. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.
Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L
Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
